- Report
- April 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- January 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- January 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- July 2025
- 371 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 280 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 379 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- April 2025
- 182 Pages
Global
From €3422EUR$3,825USD£2,962GBP
€4026EUR$4,500USD£3,485GBP
- Report
- February 2025
- 185 Pages
Global
From €3422EUR$3,825USD£2,962GBP
€4026EUR$4,500USD£3,485GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1118EUR$1,250USD£968GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1342EUR$1,500USD£1,162GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1342EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1790EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1118EUR$1,250USD£968GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1118EUR$1,250USD£968GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1790EUR$2,000USD£1,549GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1342EUR$1,500USD£1,162GBP
- Report
- June 2025
- 150 Pages
Global
From €2415EUR$2,699USD£2,090GBP
- Report
- June 2025
- 200 Pages
Global
From €2495EUR$2,789USD£2,160GBP
- Report
- May 2025
- 134 Pages
Global
From €13417EUR$14,995USD£11,614GBP
- Report
- December 2024
- 59 Pages
Global
From €3575EUR$3,995USD£3,094GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more